SYSTEMATIC REVIEW AND META-ANALYSIS OF BRIAKINUMAB, A FULLY HUMAN INTERLEUKIN 12/23 MONOCLONAL ANTIBODY, FOR THE TREATMENT OF MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS

被引:0
|
作者
Vsn, M.
Mothe, R. K.
Hyderboini, R. K.
Likhar, N.
Ganji, K.
Singuru, S.
Dang, A.
机构
[1] MarksMan Healthcare Solut LLP, Hlth Econ & Outcomes Res HEOR, Navi Mumbai, India
[2] RWE, Navi Mumbai, India
关键词
D O I
10.1016/j.jval.2016.03.494
中图分类号
F [经济];
学科分类号
02 ;
摘要
PSS5
引用
收藏
页码:A123 / A123
页数:1
相关论文
共 50 条
  • [41] Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points
    Puig, L.
    Lopez, A.
    Vilarrasa, E.
    Garcia, I.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (12) : 1633 - 1653
  • [42] Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis
    Andrea Chiricozzi
    Antonio Costanzo
    Maria Concetta Fargnoli
    Piergiorgio Malagoli
    Stefano Piaserico
    Paolo Amerio
    Giuseppe Argenziano
    Nicola Balato
    Federico Bardazzi
    Luca Bianchi
    Carlo Giovanni Carrera
    Andrea Conti
    Paolo Dapavo
    Clara De Simone
    Francesco Loconsole
    Ada Lo Schiavo
    Giovanna Malara
    Maria Letizia Musumeci
    Aurora Parodi
    Ketty Peris
    Francesca Prignano
    Franco Rongioletti
    Marina Talamonti
    Concetta Potenza
    European Journal of Dermatology, 2021, 31 : 3 - 16
  • [43] Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis
    Chiricozzi, Andrea
    Costanzo, Antonio
    Fargnoli, Maria Concetta
    Malagoli, Piergiorgio
    Piaserico, Stefano
    Amerio, Paolo
    Argenziano, Giuseppe
    Balato, Nicola
    Bardazzi, Federico
    Bianchi, Luca
    Carrera, Carlo Giovanni
    Conti, Andrea
    Dapavo, Paolo
    De Simone, Clara
    Loconsole, Francesco
    Lo Schiavo, Ada
    Malara, Giovanna
    Musumeci, Maria Letizia
    Parodi, Aurora
    Peris, Ketty
    Prignano, Francesca
    Rongioletti, Franco
    Talamonti, Marina
    Potenza, Concetta
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (01) : 3 - 16
  • [44] Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis
    Bellinato, Francesco
    Gisondi, Paolo
    Girolomoni, Giampiero
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (01) : 86 - 96
  • [45] Placebo Response in Phase 3 Trials of Systemic Therapies for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis
    Ambikaibalan, Danni
    Quaade, Anna Sophie
    Halling, Anne-Sofie
    Thyssen, Jacob P.
    Egeberg, Alexander
    DERMATOLOGY, 2021, 237 (02) : 158 - 165
  • [46] Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis
    Tada, Yayoi
    Watanabe, Rei
    Noma, Hisashi
    Kanai, Yasumasa
    Nomura, Takanobu
    Kaneko, Kenji
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2020, 99 (01) : 53 - 61
  • [47] Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL-12/23p40, in Patients With Moderate to Severe Plaque Psoriasis
    Zhu, Yaowei
    Hu, Chuanpu
    Lu, Ming
    Liao, Sam
    Marini, Joseph C.
    Yohrling, Jennifer
    Yeilding, Newman
    Davis, Hugh M.
    Zhou, Honghui
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (02): : 162 - 175
  • [48] Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-analysis
    Xue, Weiguang
    Saharia, Paranjoy
    Gray, Emma
    Khoudigian-Sinani, Shoghag
    Gaudet, Veronique
    Barbeau, Martin
    Papp, Kim
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2020, 24 (06) : 561 - 572
  • [49] Efficacy and safety of biologics targeting IL-17 and IL-23 in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials
    Cui, Lian
    Chen, Rongfen
    Subedi, Smriti
    Yu, Qian
    Gong, Yu
    Chen, Zeyu
    Shi, Yuling
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 62 : 46 - 58
  • [50] META-ANALYSIS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS
    Hawkins, N. S.
    Huntley, A.
    Eaton, J.
    VALUE IN HEALTH, 2009, 12 (03) : A74 - A75